These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6932948)

  • 1. 125IUdR loss as a measure of tumour cell loss: influence of reutilization and influx of labelled host cells.
    Franko AJ; Kallman RF; Rapacchietta D; Kelley SD
    Br J Cancer Suppl; 1980 Apr; 4():69-73. PubMed ID: 6932948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of x-irradiation on cell loss in five solid murine tumours, as determined by the 125IUdR method.
    Kelley SD; Kallman RF; Rapacchietta D; Franko AJ
    Cell Tissue Kinet; 1981 Nov; 14(6):611-24. PubMed ID: 7296627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell loss and influx of labeled host cells in three transplantable mouse tumors using [125I]UdR release.
    Franko AJ; Kallman RF
    Cell Tissue Kinet; 1980 Jul; 13(4):381-93. PubMed ID: 7428012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 125IUDR labelling efficiency and cytotoxicity for murine tumours in vivo and in vitro.
    Hagmar B; Ryd W
    Eur J Nucl Med; 1982; 7(3):108-14. PubMed ID: 7067712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reutilization of 125I-UdR during growth of a solid mammary carcinoma: implications for the 125I-UdR loss technique.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Strahlenther Onkol; 1987 Nov; 163(11):723-8. PubMed ID: 3686335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 125I-5-iodo-2'-deoxyuridine labelling on murine tumour cells.
    Bishop CJ; Sheridan JW; Donald KJ
    Br J Exp Pathol; 1981 Feb; 62(1):22-6. PubMed ID: 6784742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 125IUdR technique for measuring the cell loss from subcutaneously growing canine transmissible venereal tumours.
    Holmes JM
    Res Vet Sci; 1981 Nov; 31(3):306-11. PubMed ID: 7342225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
    Humm JL; Bagshawe KD; Sharma SK; Boxer G
    Br J Radiol; 1991 Jan; 64(757):45-9. PubMed ID: 1998837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
    Bagshawe KD; Sharma K; Southall PJ; Boden JA; Boxer GM; Patridge TA; Antoniw P; Pedley RB
    Br J Radiol; 1991 Jan; 64(757):37-44. PubMed ID: 1998836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of in vivo tumor cell destruction after specific immunization.
    Orbach-Arbouys S; Bravo-Cuellar A; Lhéritier J
    Anticancer Res; 1989; 9(1):97-101. PubMed ID: 2705762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic field affects thymidine kinase in vivo.
    Feinendegen LE; Mühlensiepen H
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):723-30. PubMed ID: 3873439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotoxicity of 5-[125I]iodo-2'-deoxyuridine in mammalian cells following treatment with 5-fluoro-2'-deoxyuridine.
    Kassis AI; Guptill WE; Taube RA; Adelstein SJ
    J Nucl Biol Med (1991); 1991; 35(3):167-73. PubMed ID: 1840093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dietary restriction, adrenaline, hydrocortisone and surgery on the rates of death of 125IUdR-labelled, intravenously injected tumour cells in the lungs of mice.
    Bishop CJ; Sheridan JW; Ablett G; Donald KJ
    Aust J Exp Biol Med Sci; 1982 Feb; 60(Pt 1):55-71. PubMed ID: 6807273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of 5-iododeoxyuridine as a measure of tumor growth and tumor inhibition.
    Bonmassar E; Houchens DP; Fioretti MC; Goldin A
    Chemotherapy; 1975; 21(6):321-9. PubMed ID: 1183242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes.
    Kassis AI; Sastry KS; Adelstein SJ
    Radiat Res; 1987 Jan; 109(1):78-89. PubMed ID: 3809393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients with breast cancer.
    Mariani G; Collecchi P; Giuliani L; Baranowska-Kortylewicz J; Di Luca L; Meucci G; Viacava P; Van den Abbeele AD; Salvadori PA; Di Sacco S
    Ann N Y Acad Sci; 1993 Nov; 698():204-11. PubMed ID: 8279758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effect of 125IUdR on the glioma cell line C6 in vitro and in vivo].
    Wu B; You C; Liu XD; Cai BW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):671-4. PubMed ID: 15460416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine.
    Makrigiorgos GM; Kassis AI; Baranowska-Kortylewicz J; McElvany KD; Welch MJ; Sastry KS; Adelstein SJ
    Radiat Res; 1989 Jun; 118(3):532-44. PubMed ID: 2727274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro 125IUdR-release assay for measuring the kinetics of cell death.
    Schneiderman MH; Hofer KG; Schneiderman GS
    Int J Radiat Biol; 1991 Feb; 59(2):397-408. PubMed ID: 1671690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The elimination of i. v.-injected tumor cells. Studies with 125IUDR labelled cells in 4 syngeneic murine tumor systems.
    Ryd W; Hagmar B
    Acta Pathol Microbiol Immunol Scand A; 1984 Jan; 92(1):23-30. PubMed ID: 6702457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.